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Abstract
Objective To evaluate the effectiveness on glycaemic control of a training
programme in consultation skills for paediatric diabetes teams.
Design Pragmatic cluster randomised controlled trial.
Setting 26 UK secondary and tertiary care paediatric diabetes services.
Participants 79 healthcare practitioners (13 teams) trained in the
intervention (359 young people with type 1 diabetes aged 4-15 years
and their main carers) and 13 teams allocated to the control group (334
children and their main carers).
Intervention Talking Diabetes programme, which promotes shared
agenda setting and guiding communication style, through flexible menu
of consultation strategies to support patient led behaviour change.
Main outcome measures The primary outcome was glycated
haemoglobin (HbA1c) level one year after training. Secondary outcomes
were clinical measures (hypoglycaemic episodes, body mass index,
insulin regimen), general and diabetes specific quality of life, self reported
and proxy reported self care and enablement, perceptions of the diabetes
team, self reported and carer reported importance of, and confidence
in, undertaking diabetes self management measured over one year.
Analysis was by intention to treat. An integrated process evaluation
included audio recording a sample of 86 routine consultations to assess
skills shortly after training (intervention group) and at one year follow-up
(intervention and control group). Two key domains of skill assessment
were use of the guiding communication style and shared agenda setting.
Results 660/693 patients (95.2%) provided blood samples at follow-up.
Training diabetes care teams had no effect on HbA1c levels (intervention
effect 0.01, 95% confidence interval −0.02 to 0.04, P=0.5), even after
adjusting for age and sex of the participants. At follow-up, trained staff
(n=29) were more capable than controls (n=29) in guiding (difference in
means 1.14, P<0.001) and agenda setting (difference in proportions
0.45, 95% confidence interval 0.22 to 0.62). Although skills waned over
time for the trained practitioners, the reduction was not significant for
either guiding (difference in means −0.33, P=0.128) or use of agenda
setting (difference in proportions −0.20, −0.42 to 0.05). 390 patients
(56%) and 441 carers (64%) completed follow-up questionnaires. Some
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aspects of diabetes specific quality of life improved in controls: reduced
problems with treatment barriers (mean difference −4.6, 95% confidence
interval −8.5 to −0.6, P=0.03) and with treatment adherence (−3.1, −6.3
to −0.01, P=0.05). Short term ability to cope with diabetes increased in
patients in intervention clinics (10.4, 0.5 to 20.4, P=0.04). Carers in the
intervention arm reported greater excitement about clinic visits (1.9, 1.05
to 3.43, P=0.03) and improved continuity of care (0.2, 0.1 to 0.3, P=0.01).
Conclusions Improving glycaemic control in children attending specialist
diabetes clinics may not be possible through brief, team-wide training
in consultation skills.
Trial registration Current Controlled Trials ISRCTN61568050.
Introduction
Diabetes is the third most common chronic disease in childhood,
with at least 13.5 new cases per 100 000 children annually in
the United Kingdom.1 2 The control of blood glucose is an
important risk factor for complications3 and is affected by insulin
treatment, lifestyle, and psychosocial and educational
influences.4 However, management targets are realised in only
a small proportion of children.5 6 Psychoeducational
interventions, including education integrated into routine care
and continued parental involvement that encourages self efficacy
in adolescents have resulted in modest improvements in blood
glucose control in young people with diabetes.7-9 Current
evidence is predominantly available from the United States and
may be context dependent. There is also little evidence about
the effect of psychosocial or educational interventions involving
younger children. Furthermore, although trials have shown some
recent methodological improvements, most have been
underpowered to detect clinically important changes in glycated
haemoglobin (HbA1c) levels.
7 8 Evidence from the United
Kingdom on the effectiveness of psychoeducational
interventions alone in improving glycaemic control in children
is limited.9 The authors of a systematic review concluded that
although there was some evidence that theoretically based
interventions are more effective, many interventions evaluated
so far have not been explicitly theory based.7 10
Although clear evidence for the superiority of one
psychoeducational approach over another is lacking, an efficacy
study of motivational interviewing in childhood diabetes9 found
a beneficial effect on HbA1c levels. Motivational interviewing
promotes prioritising patient preference and supports patient
autonomy. It is, however, unclear whether large numbers of
practitioners delivering this intervention in a routine clinical
setting (as opposed to delivery by specialist therapists) is
effective.11 12
The delivery of diabetes care to children in the United Kingdom
is usually located in secondary care and the multidisciplinary
teams include paediatricians with expertise in childhood
diabetes, nurse specialists, dietitians, child psychologists,
podiatrists, and social workers. Only 21% of services, however,
report integrated specialist psychologist support.13 Therefore
the responsibility of psychoeducational support for affected
children and their families most often remains with other
members of the healthcare team. Evidence to inform decisions
about whether to invest in a limited number of specialist
psychoeducational practitioners or to train whole teams in
psychoeducational consulting skills is lacking. The whole team
approach has the benefit of increasing reach, whereas the
intensity offered by specialist practitioners may enhance
effectiveness but for fewer patients.
Therefore an important gap in the evidence base supporting
diabetes care in children was the question of the effectiveness
of broadly applicable, theoretically based, team wide training
in psychoeducational consulting skills that encourages parental
involvement and that promotes self efficacy in adolescents.
Given this lack of evidence, we carried out a phase of
intervention development and feasibility assessment. This
showed that practitioners in UK secondary care paediatric
diabetes teams recognised the importance of dealing with
psychosocial needs but lacked the confidence and training in
consultation skills to address them.14 15 Practitioners reported
challenges in engaging families in the process of care and that
available training was remote from actual clinical practice.16
Family members of affected children reported feeling that
attendance at a clinic seemed to serve the needs of clinicians
rather than those of the children and their parents and sometimes
marginalised the children themselves.17 Children and teenagers
with diabetes indicated that they wanted a more positive
approach from teams, which took greater account of the
constraints of their life world. Our research team hosted a series
of developmental workshops to integrate findings from reviews
of the evidence base with perspectives from lay and professional
stakeholders: the Stakeholder Advisory Group.18
The Talking Diabetes training programme was developed from
this process. It focused on shared setting of agendas and a
flexible style of communication by practitioners. The programme
was informed by motivational interviewing and promoted a
guiding consulting style to explore and support opportunities
to change health related behaviours, whichmay lead to improved
metabolic control. The programme provided a menu of
consultation strategies, and practitioners were trained to use it
through a combination of web based training and two
workshops. We evaluated the effectiveness of training teams
using the Talking Diabetes programme in improving glycaemic
control and the quality of life of young people with diabetes.
We hypothesised that practitioners trained using the programme
would support young people to manage their diabetes better
resulting in a lower mean HbA1c level than in young people
cared for by untrained teams.
Methods
We present a pragmatic, cluster randomised controlled trial of
the Talking Diabetes programme within UK clinical practice.
The methods have been described in detail previously.19Briefly,
the evaluation phase of the Talking Diabetes training
programme, known as the DEPICTED (the Development and
Evaluation of a Psychosocial Intervention in Children and
Teenagers Experiencing Diabetes) study was set in UK
secondary care. An economic analysis was carried out alongside
the trial and is reported elsewhere.20
Centres and participants
Centres were identified and approached during the development
phase of the study using an augmented specialist register of UK
services.15Of the centres expressing an interest, 30 were invited
to participate based on entry criteria (minimum eligible clinic
list size of 40, at least one paediatrician with an interest in
diabetes, and a diabetes specialist nurse). Families were eligible
for participation if their child had type 1 diabetes diagnosed no
less than 12 months earlier, was aged between 4 and 15 years,
was not expected to leave the care of the participating centre
for the duration of the study, and if both child and one parent
or carer were able to complete study materials and provide
adequate informed consent. Children were not eligible if they
were not being looked after by either their parent or their
guardian, had a comorbidity that was likely to affect their HbA1c
measurement, were in receipt of psychiatric or psychological
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therapy, or were clinically judged to be vulnerable owing to
social circumstances or an existing medical condition.
Recruitment and centre randomisation
A locally employed research nurse identified and approached
eligible families before randomisation by centre. For each centre,
a random sample of 40 children was selected by the trial team
using anonymised clinic lists with the aim of obtaining 30
recruited children. Families were approached by letter and
recruited after written informed consent from both parent and
child (assent in the case of younger patients). Recruitment and
randomisation were undertaken in three blocks but with patients
in each centre being approached en bloc by letter.21 Each
participating centre was allocated to undertake training in the
Talking Diabetes programme either before (intervention group)
or at the end (control group) of a one year study period.
Randomisation was optimally balanced for patient list size.22
The first block of centres recruited was randomised so that
intervention training could begin. Subsequent blocks of centres
were randomised, maintaining the balance for list size. The trial
statistician carried out randomisation independent of centre and
child recruitment. A statistician independent of the trials unit
allocated the intervention and control centres to the final
sequence. The allocations were then passed to the trial manager
and concealed from centres until training was arranged for
intervention centres.
Intervention
The training programme aimed to prepare practitioners for more
constructive consultations about behaviour change by placing
patients at the centre of their own consultation and enhancing
engagement with their own healthcare.19 Training emphasised
shared setting of agendas and a guiding communication style,
as well as discrete strategies and skills drawn frommotivational
interviewing practice. Role played interactions modelled how
the strategies could be flexibly deployed in routine
consultations.23 24 The shared agenda setting was supported by
a physical tool (3T: TimeToTalk, produced by Cardiff
University), which was a pad of sheets with images of young
people and encircled discussion topics including adequate blank
space and empty circles for the young people and their carers
to record and review agenda items with clinic staff. Training of
practitioners was delivered through web based modules, which
comprised formal didactic content (about 1.5 hours) and
interactive components. Additionally, two team based day
workshops, delivered about two weeks apart by two trainers,
provided opportunities to review and practice intervention
strategies and skills. After the second workshop, practitioners
were able to report consultations online and to receive feedback
from the trainer team. The bespoke and manualised training
programme was constructed around three case studies
representing common clinical challenges in paediatric diabetes
care. Once trained, practitioners were expected to conduct
modified consultations with their patients for the remainder of
the 12 month study period, as part of otherwise routine care.
Primary and secondary outcomes (measured
at patient level)
The primary outcome measure was HbA1c level measured at
baseline and at one year using capillary blood samples collected
by local research nurses and assayed at a single central
laboratory. Values were reported after adjustment against the
Diabetes Control and Complications Trial (DCCT) international
standard. Secondary patient reported outcomes included diabetes
specific quality of life, patient enablement, perceptions of the
diabetes team, and self care.25-30 (See supplementary table on
bmj.com for details of secondary outcomes.) Secondary carer
reported outcomes included diabetes specific quality of life and
enablement and perceptions of the diabetes team. Parent reported
proxy measures (for children under 11 years) included diabetes
specific quality of life and self care. Novel single itemmeasures
of clinic related affect (for example, feeling fed up, excited,
guilty, good, worried) were also included in carer and all patient
questionnaires. Effective behaviour change can be viewed as
the combined effect of the importance attached to changing a
behaviour and the confidence of an individual to achieve such
change.31 Therefore we developed two new six item scaled
measures of importance and confidence in managing diabetes
and evaluated these for inclusion as outcomes for older children
(≥11 years) and carers.
At baseline, questionnaires were handed to families for
completion and returned direct to the trial team by post.
Follow-up questionnaires were dispatched and returned by post
directly to the trial team. An interim questionnaire assessing
enablement was also completed at the first clinic visit after the
start of the trial. A case report form recording demographic and
clinical data (including hypoglycaemic episodes, body mass
index, and insulin regimen) was completed at baseline by the
research nurse from the young people’s notes. Clinical data
were collected at each subsequent clinic visit up to and including
the one year follow-up visit.
Sample size
An individually randomised trial would require 200 young
people to detect a moderate effect size of 0.4 for HbA1c at a 5%
significance level with 80% power. Assuming an intracluster
correlation coefficient of 0.08 (based on audit data from the
Wales Paediatric Diabetes Interest Group) and 24 centres
recruiting an average of 23 young people resulted in the sample
size being inflated to 550. Adjusting this to account for a 22%
loss to follow-up resulted in a target of 700 recruited young
people. Of the 30 centres invited, four did not participate owing
to a withdrawal of interest or inability to complete agreements
in time. The target number of centres was finally increased by
two (to 26) to allow for withdrawal of centres.
Statistical analysis
The primary analysis was by intention to treat, comparing HbA1c
values between study groups at one year follow-up. The
distribution of HbA1c data was positively skewed and a natural
log transformation performed for regression analysis. Multilevel
modelling was adjusted for cluster (centre) and individual
effects. Baseline levels of HbA1c were included as a covariate.
Primary analysis involved a two level linear model and included
interaction terms for both age and sex with treatment allocation.
The influence of missing data was examined by replacing
missing trial HbA1c values with routine clinic values where
possible. Analysis of secondary outcomes also used multilevel
modelling and incorporated baseline scores as covariates.
Variations in the skewness of outcome data were all within
limits of the methods used, and scores remained untransformed
for modelling. No interim analyses were planned or undertaken.
Process evaluation
The process evaluation focused on two substantive components:
the adequacy of training delivery and fidelity to the menu of
guiding skills and strategies. The adequacy of training involved
assessing level and quality of engagement by practitioners with
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the training materials (access to online learning modules,
attendance at the two workshops, and provision of clinical case
feedback to trainers after training). The guiding skills and
strategies component involved rating a sample of audio recorded
clinical consultations across the trial sites. In addition,
representatives of each intervention arm clinical team were
interviewed by telephone at the end of the study period to
determine how the interventionwas received by teams (including
factors that were seen to hinder or facilitate implementation),
and perceptions of the impact of training on practitioner
performance. Transcribed data from the semistructured
interviews were subject to coding and inductive analysis led by
one member of the research team (ETJ), with additional input
from two other experienced social researchers. The results of
the interview study are fully reported elsewhere, and are
summarised here.20
Audio recording routine consultations enabled assessment of
the practitioners’ performance using an adapted measurement
scale.19 20 Items assessed performance across five domains:
overall adherence to guiding style, agenda setting, and each of
the three consultation strategies (exploring the pros and cons
of change, importance and confidence about making changes,
and brainstorming). Items from an existing measure of
motivational interviewing practice were supplemented with
those dealing with intervention specific content.32 Recordings
were collected from intervention group practitioners immediately
after training and at one year, and from control group
practitioners before training at the end of the one year study.
Practitioners were asked to record all consultations within a
single clinical session (where consent could be obtained) and
to nominate two consultations where a behaviour change issue
was discussed (although analysis could have included any
consultation in that session). To collect recordings we randomly
selected a maximum of three practitioners per clinic. Where
available, two consultations per practitioner were selected at
random for further analysis (two recordings per practitioner,
per time point for the intervention group). All recordings
selected were scored by a single trained rater and one in four
additionally rated by a second rater. Raters were blinded to
treatment allocation, based with the trial team, and unfamiliar
to the practitioners whose consultations were being assessed.
Where practitioner recordings were rated by two raters, κ
statistics were used to assess reliability and were between 0.49
and 0.88 for 10 of the 12 scales rated (indicating moderate to
excellent agreement) but lower for shared agenda setting use
and skilfulness (0.27 and 0.30, respectively).
Results
Twenty six centres participated and recruited 693 young people
with type 1 diabetes between August 2007 and January 2008
(figure⇓). Table 1⇓ shows the baseline characteristics of the
participants by study allocation. Although more intervention
centres than control centres reached their recruitment targets,
the characteristics were adequately balanced across arms,
including HbA1c levels. Adjusting for sex in the primary analysis
to account for the slight excess of boys in the intervention arm
did not alter the results. To reduce bias from knowledge of
allocation, recruitment was attempted before revealing the centre
allocation and was achieved for 213 patients (30.7%). No
evidence of bias was found when baseline data were compared
between groups recruited before and after revealing treatment
allocation.
Seventy nine practitioners received training across the 13
intervention centres and reported enthusiasm for the training
package (including online and workshops).20
Primary outcome
Baseline HbA1c measurements were obtained from 356/359
(99.2%) young people in the intervention arm and 333/334
(99.7%) in the control arm and from 342 (95.3%) and 318
(95.2%) respectively at follow-up. HbA1c levels increased in
both groups during the study period. The mean (SD) HbA1c for
the control group was 9.5 (1.7) and for the intervention group
was 9.7 (1.7) at follow-up. The intervention effect adjusted for
baseline HbA1c level (log transformed data) was 0.01 (95%
confidence interval −0.02 to 0.04, P=0.50, intraclass correlation
coefficient 0.057) and was not significant. Adding values from
routine clinic data for missing outcome data did not alter the
result (missing data were only evident for three young people
in the control group and seven in the intervention group). Sex
was significantly associated with HbA1c level at follow-up, but
adjusting for age and sex did not alter the results and no
significant interactions were evident between treatment
allocation and age or sex.
Patient and carer secondary outcomes
Overall, 390 young people (56%) and 441 carers (64%)
completed follow-up questionnaires at 12 months (figure).
Among the young people there was no intervention effect on
perceptions of the team providing healthcare (table 2⇓). Of the
quality of life subscales, the control group showed a small
improvement in problems with treatment barriers and a
borderline improvement in problems with treatment, which was
not found for the intervention group (table 2). No other
differences were evident in standardised secondary outcomes
for the young people at 12months (tables 2 and 3⇓). Enablement
scores were higher for intervention patients in the short-term,
but this advantage was not sustained to 12 months (table 2).
Two six itemmeasures of importance and confidence in diabetes
self management developed for the study showed adequate
construct validity at baseline (factor analysis showing a single
factor solution in each case, and Cronbach’s α above 0.84 for
both patient and carer versions). No significant intervention
effect was found for either measure (table 2).
Among carers, there was no evidence of an intervention effect
on perceptions of the healthcare team, or on any of the quality
of life subscale scores (table 4⇓). A significant intervention
effect was found on perceptions of continuity of care with
improvements for the intervention group and deterioration for
the control group (table 4). Carers in the intervention group felt
more excited about prospective visits to the clinic (table 5⇓),
but no other differences were shown between the study groups
on the standardised or newly derived outcome measures (tables
4 and 5).
Safety of treatment and clinical outcomes
No reports of serious adverse events reported to the trial team
were judged to be related to the intervention. The intervention
had no effect on hypo episodes, body mass index, or insulin
regimen.
Process evaluation
Across the 13 clinical teams in the intervention arm of the study,
75 practitioners were eligible to be trained at study baseline. Of
these, 71 (94.7%) attended one or both of the workshops and
all logged onto the online training. After the start of the study
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period, a further four practitioners began working within one
of the 13 centres, and all made attempts to access the online
training at some point. The mean (SD) duration of time spent
logged onto the web site by each practitioner was 217 minutes
(137 minutes). After the second workshop, 43 practitioners
provided either partial or full reporting of clinical case data to
the training team for feedback.
In total, 170 valid recordings of consultations were obtained
(19 clinicians from 10 of the 13 intervention centres provided
data immediately after training, 30 clinicians from 13 of the 26
trial centres returned useable data at the one year follow-up).
At one year, the intervention group practitioners had better
scores for guiding style (general style, evocation, collaboration,
and autonomy-supportive) than did the control group
practitioners (table 6⇓). For the intervention group, guiding style
scores decreased over time, but this difference was only
significant for evocation (table 6). At one year, agenda setting
and brainstorming were more commonly observed in the
intervention group than were pros and cons or importance and
confidence (table 7⇓). The skilfulness by which these were
applied by intervention practitioners did not significantly alter
over time (table 8⇓).
The times patients and carers reported that they spent either
individually (parent only or child only) or together with various
health professionals at the clinic was recorded on case report
forms. The mean (SD) reported total time was 99.92 (56.30)
minutes for intervention clinics and 104.79 (69.60) minutes for
control clinics. The difference was not significant (P=0.32).
During the trial period, 11/334 (3.3%) young people in the
control arm did not attend the clinic at all compared with 4/359
(1.1%) in the intervention arm (difference 2.2, 95% confidence
interval −0.1 to 4.8). The mean (SD) number of clinic visits
was 3.5 (1.1) for participants in both the intervention and the
control arm. To investigate possible dose-effect, the number of
clinic visits was added to the multilevel model for the primary
outcome. The number of visits was not statistically significant
and the interaction between number of visits and trial arm was
not significant.
Eleven nurses, one dietitian, and one doctor from the
intervention centres were interviewed. Results of the main
interview analysis are reported elsewhere.20 The following key
observations were, however, reported by interviewees. The
agenda setting tool was variably used by clinical teams, some
of whom sent it out to patients in advance of attending the clinic,
somemaking it available on arrival or in the actual consultation.
Respondents reported a reduction in use over time, perhaps
because issues may have already been raised and tackled in
previous consultations, although several teams reported
continued attempts to use the principle of a shared agenda setting
approach. Interviewees positively appraised the training and
valued the whole team approach. Facilitators of implementation
included a physical aide memoire of the menu of strategies and
opportunities that were taken by some teams for team based
reflection. Barriers included the perceived time required to
practice and master intervention skills and time constraints
associated with busy clinics. However, many interviewees
reported confidence in their ability to implement new skills over
time. Staff turnover was also reported to be a barrier to effective
implementation. Despite such barriers, most interviewees
considered that consultations had shifted away from clinical
outcomes towards the needs of the child, facilitated by a
structured but open consultation with a less directive approach.
Many felt that their practise had changed but with variable levels
of skilfulness.
Discussion
This multicentre, pragmatic trial evaluated the effectiveness of
a complex psychoeducational consulting skills intervention,
which aimed to enable all clinical members of paediatric
diabetes care teams to facilitate improved metabolic control in
their patients. We found that training paediatric teams in the
Talking Diabetes intervention did not improve glycaemic
control, had a negative impact on some aspects of quality of
life in the young people one year after practitioner training, but
had a short term beneficial effect on coping. The theory based
intervention was developed with a high level of stakeholder
input and included agenda setting and the flexible use of
consultation styles with a greater focus on the “guiding” style
along with other strategies drawn from motivational
interviewing,33 and aimed to improve psychoeducational
consultation skills and practice in all members of the care team.
Some benefits of the intervention on perceived continuity of
care and feeling excited about clinic visits were observed in
carers, but similar improvements were not seen in the children.
Whereas these represent secondary outcomes in this study, the
former findings are welcome given concerns expressed by
parents during intervention development about feeling
marginalised during clinic visits.
Strengths and weaknesses of the study
Intervention development included systematic review of
evidence supporting effective psychoeducational interventions
in managing childhood diabetes and incorporated viewpoints
of practitioners, children, and their families, including the view
that clinicians should give prominence to patient preferences
and enhance patient autonomy. Principles from motivational
interviewing, with a strong evidence base for influencing
behaviour change including within diabetes care, informed
consultation strategies.9 11 34 Presentation of the evolving
intervention to a Stakeholder Advisory Group resulted in
important modifications, including the development of the
agenda setting tool.18
The cluster trial design was appropriate to an evaluation of a
whole team consultation skills intervention where diffusion of
skills at a team level would have been welcomed. Once trained
in new consulting skills, clinicians cannot switch between using
them and not using them as would have been required with
individual patient randomisation. Also, the intervention sought
to determine the effect of a consultation skills approach deployed
over time by a particular service, so that exposure to a trained
team was necessary each time patients consulted. The delivery
of the intervention in each centre by a number of practitioners
also reduced the possibility that outcomes were a consequence
of practitioner influences such as personality, independent of
training in the intervention. Ascertainment of the primary trial
outcome was virtually complete, ensuring that the study had
adequate power to detect a meaningful effect on glycaemic
control, and minimised risk of attrition bias.
Trial centres were geographically spread and were balanced for
list size in randomisation, providing good generalisability of
the results for young people with diabetes aged 4-16 years and
their carers in the United Kingdom. The low dropout rate and
spread of attendance noted (from zero to six visits during the
study period in both trial arms) also strengthens the study
findings. There was moderate variation in HbA1c levels between
centres at follow-up (intracluster correlation coefficient of 0.06),
which is likely to reflect a combination of demographic, clinical,
and therapeutic factors differing across sites. Centre and
individual level effect were accounted for in the multilevel
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modelling analysis. We also investigated differential effects of
the intervention for differing baseline HbA1c values.
20However,
the relevant interaction term was non-significant suggesting
that the intervention effect did not vary by initial level of
glycaemic control.
Although the practitioners skill levels after training were greater
in the intervention centres than in the control centres, the
absolute levels achieved were disappointing when compared
with the theoretically derived scale endpoints (with average
scores for those recently trained just below the scale mid-point).
A competency assessment for practitioners after training may
have ensured greater fidelity to the delivery of the intervention
but would have been difficult to implement. Furthermore,
performance diminished over time, suggesting that
reinforcement of training was required. Training aimed to
enhance consulting skills but not meaningfully increase the
duration of consultations. Coverage of trained practitioners by
consultation recordings was lower than expected, although was
much better at follow-up than at baseline for the intervention
group. This was the combined result of practical challenges of
collecting audio data in busy routine clinics, requirements for
adequately documented consent, technical difficulties in
capturing and transferring digital audio, and probably some
natural reticence of the practitioners about being recorded. This
could therefore have introduced some ascertainment bias into
the dataset, although the subsequent selection process for
analysis sought to minimise any further selection bias. Although
it is possible that the more confident and skilful practitioners
were also more likely to provide recordings and hence
over-estimate the training effect, evidence of such an effect is
still provided.
While the process evaluation confirmed no increase in
consultation length, a potentially negative consequence was
only brief exposure of child and family to trained clinicians
during the year of follow-up (generally three to four clinic visits
per year with a total contact time with all practitioners of less
than an hour). This was typically less than in previous trials of
motivational interviewing and other psychoeducational
interventions. For example, in a study in 2007, mean contact
time was four sessions of about 45 minutes each, involving the
same practitioner and carried out independently from the
diabetes clinic.9
Most of the practitioners initially identified within each
intervention arm team received some or all of the blended
training. Once trained, it proved harder for the trainers to directly
engage with practitioners to reinforce good practice as planned.
Changes to team staff over time probably decreased the potential
impact of training, and although web based training remained
available for the duration of the study, additional face to face
workshops were not usually feasible for incoming staff. Teams
varied in their approach to integrating the intervention within
their clinic setting and some showed considerable enthusiasm
and engagement in developing local ownership. Although the
research team and trainers provided generic guidance and tools
to support implementation, delivering a low resource
intervention that could thus be rolled out more broadly in routine
clinics placed restrictions on what could have been otherwise
achieved.
The primary trial outcome was chosen as an objective global
indicator of disease management with established associations
with longer term complications. It also has strong clinical
validity for practitioners, parents, and children. It is nevertheless
a distal outcome for an intervention that is delivered to
practitioners andmediated through clinical consultations, aiming
to change patients’ attitudes and behaviour. Furthermore, with
a consultation agenda that was shared between practitioner and
child, not all changes in behaviour that may have been discussed
would have been expected to have had either an immediate or
even a potential impact on glycaemic control. We therefore
placed some emphasis on the importance of quality of life as a
key secondary outcome in this trial, and expect that such
outcomes will increasingly feature as primary outcomes in the
future trials of similar interventions for complex behaviour
change.
Building on evidence that outcomes for young people with
diabetes are better where parents remain involved in a negotiated
manner in their child’s care, the training programme produced
an intervention that aimed to influence both the children and
their carers.35 It is of interest that parents in the intervention arm
reported greater continuity of care than those in the control arm
and did not report reduced confidence in their ability to manage
the illness as reported by their children. Parents may have
benefitted more from the intervention than their children and
might be better placed to provide ongoing support to their
children as a consequence of care by teams exposed to the
intervention.
Comparison with other studies
Systematic reviews of psychoeducational interventions in
children and adolescents with diabetes report a modest beneficial
effect on psychological and metabolic outcomes,7 36 although
few interventions have targeted younger children.12 A further
concern has been the lack of UK based studies, limited data on
cost effectiveness, and the use of diabetes specific interventions,
which have been poorly described, all making replicability and
applicability difficult to assess.7 8 Most interventions have been
multifaceted making it difficult to identify which aspects have
been most responsible for change. The studies included in the
review were often short term, underpowered, not pragmatic,
and with interventions delivered by specialists within teams
rather than by whole team approaches. It is possible that the
effect of the Talking Diabetes intervention will be seen on
metabolic control in children after one year (the follow-up period
in our study), and that psychosocial and quality of life outcomes
are more proximal effects. Some studies of motivational
interviewing in diabetes have found positive effects two years
after the start of the intervention (for example9). However, the
intervention effect at two years described in the previous study
was preceded by a similar advantage at one year, unlike the
present study. This comparison therefore does not support a
search for longer term benefits of the Talking Diabetes
intervention. It nevertheless remains possible that the short term
benefit in coping and the longer term negative impact on health
related aspects of diabetes quality of life may indicate some
longer term impact of the intervention, but further investigation
would be required into potential mechanisms.
Our study attempted to tackle these limitations by delivering a
theoretically driven, manualised intervention for use by a range
of practitioners dealing with a wide age range of children, using
clearly defined theoretical principles and strategies, with patient
related outcomes assessed one year after training practitioners.
Our study therefore differed from the efficacy study of
motivational interviewing in childhood diabetes in that it
involved training whole teams to deliver the intervention within
routine clinical care rather than evaluating an intervention
delivered by a single specialist practitioner.9 11 Furthermore, to
make the intervention broadly deliverable in a routine clinic
setting, its content was drawn from, but did not fully equate to,
motivational interviewing. The added value of incorporating
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reflective listening into the existing programmemenu of guiding
skills and strategies remains undetermined.
Implications for research and practice
Although welcomed by practitioners, our findings suggest that
training in psychoeducational consultation skills for whole teams
does not improve glycaemic control in young people with
diabetes over one year. In the light of this new evidence
therefore, such training in its current format should not be rolled
out in the UKNational Health Service. The economic evaluation
undertaken within the present study20 compared whole team
training with no training but did not explore whether whole
team training was more cost effective than additional specialist
provision. While our finding of no effect on glycaemic control
suggests that this is unlikely to be the case, the scarcity of trained
clinical psychologists in UK paediatric diabetes services
suggests a need for further research to examinewhether modified
versions of the training intervention—for example, by
incorporating a reflective listening component—could improve
its clinical and cost effectiveness.37
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Tables
Table 1| Baseline characteristics of participants (data provided by children and carer) by allocation group. Values are numbers (percentages)
unless stated otherwise
OverallTraining programmeStandard careCharacteristics
Children
9.3 (1.8) (n=689)9.4 (1.7) (n=356)9.2 (1.8) (n=333)Mean (SD) HbA1c level (%)
HbA1c distribution:
76 (11)33 (9)43 (13)<7.5%
240 (35)117 (33)123 (37)7.5-9%
373 (54)206 (58)167 (50)>9%
10.6 (2.8)10.4 (2.8) (n=359)10.7 (2.8) (n=334)Mean (SD) age (years)
6.0 (3.0)5.7 (3.0) (n=255)6.3 (3.0) (n=253)Mean (SD) age (years) at diagnosis
5.1 (2.7)5.2 (2.8) (n=255)5.0 (2.7) (n=253)Mean (SD) duration (years) of diabetes
342 (49)187 (52)155 (46)Boys
19.4 (3.2)19.5 (3.2) (n=356)19.2 (3.1) (n=329)Mean (SD) body mass index
Ethnicity:
521 (91)262 (91)259 (91)White British
12 (2)5 (2)7 (2)Other white
23 (4)12 (4)11 (4)Mixed
5 (1)4 (1)1 (<1)Black or black British
13 (2)6 (2)7 (2)Asian or Asian British
1 (<1)0 (0)1 (<1)Other
Carer providing data
572 (93)286 (93)286 (93)Carer status: mothers
570 (99)286 (99)284 (99)Usually attends clinic
565 (98)281 (99)284 (97)Provide majority of care
572 (70)286 (69)286 (71)Generally see same doctor at clinic
569 (91)284 (93)285 (89)Generally see same nurse at clinic
Socioeconomic class:
273 (57)134 (54)139 (54)Managerial and professional occupations
69 (14)38 (15)31 (12)Immediate occupations
49 (10)23 (9)26 (10)Small employers and own account workers
50 (10)28 (11)22 (9)Lower supervisory and technical occupations
67 (13)27 (11)40 (16)Semiroutine and routine occupations
Denominators vary owing to missing values (assumed to be missing at random).
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Table 2| Secondary outcomes for young people with type 1 diabetes according to allocation group. Values are means (standard deviations)
unless stated otherwise
Adjusted for baseline scoreTraining programme
No
Standard care
Variables P valueIntervention effect (95% CI)ICC (%)Follow-upBaselineFollow-upBaselineNo
0.660.04 (−0.2 to 0.2)10.14.0 (0.71)4.0 (0.69)1644.0 (0.62)4.1 (0.60)182Healthcare climate
Quality of life:
0.03−4.6 (−8.5 to −0.6)0.967.5 (21.2)66.8 (22.0)16773.3 (18.2)69.3 (19.6)186Barriers
0.60−0.9 (−4.2 to 2.4)3.355.3 (15.3)54.4 (15.0)16757.2 (14.3)56.5 (13.6)185Symptoms
0.05−3.1 (−6.3 to −0.01)076.8 (17.4)76.4 (17.2)16680.6 (15.4)77.9 (15.1)183Adherence
0.10−3.4 (−7.4 to 0.7)067.2 (23.2)68.8 (23.8)16269.8 (20.2)67.3 (22.0)181Worry
0.06−5.4 (−11.1 to 0.3)0.162.3 (26.9)63.3 (26.9)16269.1 (22.2)66.0 (23.8)181Communication
0.85−0.02 (−0.3 to 0.2)7.84.2 (0.76)4.3 (0.72)884.3 (0.66)4.5 (0.52)121Diabetes continuity in
care
0.461.8 (−3.0 to 6.6)038.9 (20.8)35.0 (21.7)8936.4 (20.6)33.6 (19.2)123Problem areas in
diabetes
0.810.2 (−0.13 to 0.17)04.0 (0.69)4.1 (0.62)894.0 (0.67)4.2 (0.66)123Importance
0.06−0.2 (−0.4 to 0)03.5 (0.77)3.7 (0.70)893.7 (0.72)3.7 (0.73)123Confidence
0.720.03 (−0.12 to 0.18)01.8 (0.60)1.6 (0.46)801.8 (0.66)1.6 (0.53)110Care/mismanagement
Patient enablement:
0.0410.4 (0.5 to 20.4)6.430.1 (32.6)28.5 (30.4)8319.7 (25.4)28.0 (28.8)116Interim
0.34−5.2 (−16.1 to 5.7)9.021.3 (27.7)28.4 (29.4)8826.4 (30.9)29.1 (30.9)12212 months
ICC=intraclass correlation coefficient.
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Table 3| Secondary outcomes for young people with type 1 diabetes according to allocation group. Values are numbers (percentages)
unless stated otherwise
P value
Adjusted for baseline (reference group=standard
care)Training programme
No
Standard care
NoIndividual item scores Odds ratio (95% CI)ICC (%)Follow-upBaselineFollow-upBaseline
0.290.7 (0.39 to 1.32)036 (43)40 (48)8461 (52)62 (51)118Check glucose >4 times a day
Experiencing emotion items*:
0.081.5 (0.95 to 2.42)1.077 9 (47)55 (34)16370 (39)62 (35)179Fed up
0.091.6 (0.93 to 2.65)0.554 (34)64 (40)16142 (23)59 (33)180Excited
0.181.6 (0.79 to 3.41)020 (12)16 (10)16116 (9)23 (13)177Guilty
0.571.1 (0.71 to 1.86)0104 (64)108 (67)162115 (64)130 (72)181Good
0.191.4 (0.85 to 2.29)6.456 (34)64 (39)16547 (26)61 (34)179Worried
0.771.07 (0.69 to 1.66)083 (52)85 (54)15993 (51)99 (54)183Living with diabetes†:
0.240.74 (0.45 to 1.22)0106 (66)107 (67)161134 (74)135 (75)181General quality of life‡
0.840.96 (0.62 to 1.48)072 (44)70 (43)16383 (46)85 (47)180Quality of life compared with last
year§
ICC=intraclass correlation coefficient.
*Reported “a little,” “quite a bit,” or “very much” in response to emotion item.
†Reported “much easier” or “easier” living with diabetes compared with last year.
‡Reported in general feeling “very happy” or “happy.”
§Reported being “happier” or “much happier” than last year.
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Table 4| Secondary outcomes for carers of young people with type 1 diabetes according to allocation group. Values are means (standard
deviations) unless stated otherwise
P value
Adjusted for baseline scoreTraining programme
No
Standard care
NoVariables Effect (95% CI)ICC (%)Follow-upBaselineFollow-upBaseline
0.130.1 (0 to 0.2)3.04.3 (0.62)4.2 (0.64)2024.2 (0.59)4.3 (0.57)209Healthcare climate
Quality of life:
0.08−2.9 (−6.1 to 0.4)059.0 (20.2)60.4 (18.7)20362.3 (17.5)61.3 (17.5)208Barriers
0.36−1.0 (−3.1 to 1.1)057.1 (14.9)56.1 (13.9)20260.0 (13.6)58.9 (13.3)209Symptoms
0.35−1.4 (−4.4 to 1.6)0.673.2 (17.3)73.9 (16.4)20375.0 (15.9)74.9 (16.3)208Adherence
0.670.8 (−2.9 to 4.6)051.9 (21.9)50.9 (24.1)20152.9 (22.2)54.6 (20.8)205Worry
0.46−1.7 (−6.2 to 2.8)064.4 (29.0)63.7 (28.0)19967.7 (25.3)66.8 (26.8)204Communication
0.010.2 (0.1 to 0.3)04.4 (0.63)4.3 (0.69)2034.2 (0.73)4.4 (0.59)208Diabetes continuity of
care
0.55−0.9 (−3.7 to 2.0)3.045.2 (20.2)45.6 (18.7)20343.0 (19.4)41.4 (17.6)209Problem areas in
diabetes
0.610.02 (−0.1 to 0.1)04.7 (0.41)4.6 (0.41)2024.7 (0.40)4.7 (0.42)208Importance
0.78−0.02 (−0.1 to 0.1)03.8 (0.73)3.7 (0.74)2033.8 (0.76)3.7 (0.66)208Confidence
0.87−0.01 (−0.10 to 0.09)01.6 (0.51)1.5 (0.47)1831.6 (0.57)1.5 (0.43)186Care/mismanagement
Enablement:
0.115.2 (−1.3 to 11.6)3.023.5 (28.4)25.1 (31.5)19016.3 (25.2)18.3 (27.8)209Interim
0.274.4 (−3.5 to 12.3)3.428.7 (35.4)24.3 (32.5)20123.9 (32.1)22.3 (29.7)20712 months
ICC=intraclass correlation coefficient.
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Table 5| Secondary outcomes for carers of young people with type 1 diabetes according to allocation group. Values are numbers (percentages)
unless stated otherwise
P value
(Reference group=control)Training programme
No
Standard care
NoIndividual item scores Odds ratio (95% CI)ICC (%)Follow-upBaselineFollow-upBaseline
0.370.25 (0.16 to 1.37)1.5103 (54)104 (55)191129 (64)132 (65)202Check glucose >4 times a day
Experiencing emotion items*:
0.631.13 (0.69 to 1.85)060 (31)51 (26)19559 (30)55 (28)200Fed up
0.031.90 (1.05 to 3.43)3.337 (20)30 (16)19023 (12)30 (15)196Excited
0.671.11 (0.68 to 1.83)057 (30)49 (26)19055 (28)49 (25)198Guilty
0.441.19 (0.76 to 1.85)2.7124 (65)133 (70)191120 (60)132 (66)200Good
0.501.16 (0.75 to 1.79)0108 (56)101 (52)193103 (52)98 (49)200Worried
0.690.91 (0.57 to 1.45)1.261 (30)71 (35)20163 (31)77 (37)206Living with diabetes†
0.060.65 (0.41 to 1.03)1.4104 (53)130 (66)197121 (59)126 (61)207General quality of life‡
0.971.01 (0.66 to 1.55)2.449 (25)66 (33)19851 (25)51 (25)207Quality of life compared with last year§
ICC=intraclass correlation coefficient.
*Reported “a little,” “quite a bit,” or “very much” in response to emotion item.
†Reported “much easier” or “easier” living with diabetes compared with last year.
‡Reported in general feeling “very happy” or “happy.”
§Reported being “happier” or “much happier.”
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Table 6| Guiding style scores in intervention and control group at various time points. Values are means (standard deviations), medians,
unless stated otherwise
Difference in means (P value*)Standard careTraining programme
Scale
Before training at end
of one year (n=29)
One year after
training (n=29)
Immediately after
training (n=28)
One year after
training−before training
One year after
training−immediately after
training
1.14 (<0.001)−0.33 (0.128)1.2 (0.47), 12.3 (0.85), 22.6 (0.91), 3Guiding style
0.90 (<0.001)−0.61 (0.039)1.1 (0.44), 12.0 (1.02), 22.6 (1.06), 3Evocation
0.83 (<0.001)−0.30 (0.188)1.5 (0.63), 12.3 (0.84), 22.6 (0.92), 3Collaboration
1.07 (<0.001)−0.26 (0.171)1.3 (0.60), 12.4 (0.82), 32.6 (0.83), 3Autonomy-supportive
*Mann-Whitney U test.
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Table 7| Proportion of control and intervention groups with task done or partially done at one year. Values are numbers (percentages)
unless stated otherwise
Difference in proportions (95% CI)Standard careTraining programme
Task
One year after training−before
training at end of one year
One year after
training−immediately after
training
Before training at end
of one year (n=29)
One year after
training (n=29)
Immediately after
training (n=28)
0.45 (0.22 to 0.62)−0.20 (−0.42 to 0.05)2 (6.9)15 (51.7)20 (71.4)Shared agenda
setting
0.10 (−0.03 to 0.26)−0.18 (−0.38 to 0.03)0 (0.0)3 (10.3)8 (28.6)Pros and cons
0.10 (−0.03 to 0.26)−0.11 (−0.30 to 0.08)0 (0.0)3 (10.3)6 (21.4)Importance and
confidence
0.21 (0.03 to 0.39)−0.33 (−0.53 to −0.08)1 (3.5)7 (24.1)16 (57.1)Brainstorming
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Table 8| Skilfulness scores in intervention group practitioners immediately after training and at one year after training. Values are means
(standard deviations), medians, unless stated otherwise
Difference inmeans (one year after training−immediately after
training) (P value*)
Training programme
Skilfulness One year after trainingNoImmediately after trainingNo
−0.23 (0.44)2.3 (0.80), 2152.5 (0.89), 220Shared agenda setting
−1.46 (0.05)1.7 (0.58), 233.1 (1.13), 38Pros and cons
−0.50 (0.58)1.7 (0.58), 232.2 (1.17), 26Importance and confidence
0.13 (0.64)2.6 (0.54), 372.4 (0.89), 216Brainstorming
*Mann-Whitney U test.
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Figure
Flow of participants through study
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e2359 doi: 10.1136/bmj.e2359 (Published 26 April 2012) Page 17 of 17
RESEARCH
